We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-20.33%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$12B
AUM Growth
-$2.98B
Cap. Flow
+$613M
Cap. Flow %
5.11%
Top 10 Hldgs %
28.69%
Holding
863
New
191
Increased
291
Reduced
251
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 24.61%
2 Healthcare 19.51%
3 Financials 13.3%
4 Consumer Discretionary 10.41%
5 Communication Services 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIII icon
676
G-III Apparel Group
GIII
$1.55B
$260K ﹤0.01%
33,800
-25,100
-43% -$572K
EGRX
677
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$258K ﹤0.01%
+5,600
New +$281K
ESSA
678
DELISTED
ESSA Bancorp
ESSA
$257K ﹤0.01%
18,800
-3,900
-17% -$62.6K
OTTR icon
679
Otter Tail
OTTR
$3.88B
$253K ﹤0.01%
5,700
-12,500
-69% -$623K
HRC
680
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$252K ﹤0.01%
+2,500
New +$259K
PPLI
681
People Inc
PPLI
$3.33B
$251K ﹤0.01%
+7,834
New +$310K
VICR icon
682
Vicor
VICR
$10.4B
$249K ﹤0.01%
+5,600
New +$266K
AIT icon
683
Applied Industrial Technologies
AIT
$13.2B
$247K ﹤0.01%
+5,400
New +$319K
NIC icon
684
Nicolet Bankshares
NIC
$3.66B
$244K ﹤0.01%
4,475
-10,125
-69% -$681K
HCKT icon
685
Hackett Group
HCKT
$280M
$240K ﹤0.01%
18,900
-56,100
-75% -$842K
HMSY
686
DELISTED
HMS Holdings Corp.
HMSY
$240K ﹤0.01%
+9,500
New +$248K
TBI
687
Trueblue
TBI
$305M
$236K ﹤0.01%
+18,500
New +$331K
CEVA icon
688
CEVA Inc
CEVA
$973M
$234K ﹤0.01%
+9,400
New +$261K
ZNGA
689
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$234K ﹤0.01%
34,188
+8,400
+33% +$55.2K
ACRE
690
Ares Commercial Real Estate
ACRE
$257M
$229K ﹤0.01%
32,700
+19,900
+155% +$282K
AKAM icon
691
Akamai
AKAM
$18B
$225K ﹤0.01%
+2,460
New +$228K
SHOO icon
692
Steven Madden
SHOO
$3.55B
$223K ﹤0.01%
+9,600
New +$333K
BELFB
693
Bel Fuse Inc Class B
BELFB
$4.31B
$219K ﹤0.01%
22,451
-1,300
-5% -$18.9K
IBN icon
694
ICICI Bank
IBN
$109B
$217K ﹤0.01%
25,500
-7,900
-24% -$105K
CDR
695
DELISTED
Cedar Realty Trust, Inc
CDR
$215K ﹤0.01%
34,909
-894
-2% -$13.8K
BRKL
696
DELISTED
Brookline Bancorp
BRKL
$214K ﹤0.01%
19,000
-31,000
-62% -$442K
NVDA icon
697
NVIDIA
NVDA
$5.36T
$211K ﹤0.01%
+32,000
New +$202K
TBBK icon
698
The Bancorp
TBBK
$3B
$211K ﹤0.01%
34,800
+9,900
+40% +$106K
PHM icon
699
Pultegroup
PHM
$25.5B
$210K ﹤0.01%
9,424
-35,965
-79% -$1.39M
VNDA icon
700
Vanda Pharmaceuticals
VNDA
$311M
$207K ﹤0.01%
+20,000
New +$248K

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2020 Portfolio in Review

As of Q1 2020, Grantham, Mayo, Van Otterloo & Co (GMO) held 863 positions worth $12B, down 20% from $15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) deployed $613M of net new capital in Q1 2020, opening 191 new positions and adding to 291 existing holdings. Its largest new stake was Quest Diagnostics: 1,373,100 shares worth $110M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $99.6M trimmed.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2020 buy was Quest Diagnostics: 1,373,100 shares worth $110M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Coca-Cola in Q1 2020, an estimated $150M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2020 reduction was Alphabet (Google) Class C, cutting an estimated $99.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Mastercard in Q1 2020, selling an estimated $151M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 29% of its $12B portfolio in Q1 2020.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 191 new positions and closed 118 in Q1 2020.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 20% quarter-over-quarter to $12B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2020, filed 14 May 2020.